ACLY Antibody (C-term) Blocking Peptide

Artikelnummer: ABT-BP6784B
Artikelname: ACLY Antibody (C-term) Blocking Peptide
Artikelnummer: ABT-BP6784B
Hersteller Artikelnummer: BP6784b
Alternativnummer: ABT-BP6784B-500UG
Hersteller: Abcepta
Kategorie: Proteine/Peptide
Alternative Synonym: ATP-citrate synthase, ATP-citrate (pro-S-)-lyase, ACL, Citrate cleavage enzyme, ACLY
ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. The enzyme is a tetramer (relative molecular weight approximately 440,000) of apparently identical subunits. It catalyzes the formation of acetyl-CoA and oxaloacetate from citrate and CoA with a concomitant hydrolysis of ATP to ADP and phosphate. The product, acetyl-CoA, serves several important biosynthetic pathways, including lipogenesis and cholesterogenesis. In nervous tissue, ATP citrate-lyase may be involved in the biosynthesis of acetylcholine.
NCBI: 47
UniProt: P53396
Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP6784b was selected from the C-term region of human ACLY. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.